Literature DB >> 12898521

Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.

Melody Baddoo1, Katy Hill, Robin Wilkinson, Dina Gaupp, Catherine Hughes, Gene C Kopen, Donald G Phinney.   

Abstract

Mesenchymal stem cells (MSCs) are typically enriched from bone marrow via isolation of the plastic adherent, fibroblastoid cell fraction. However, plastic adherent cultures elaborated from murine bone marrow are an admixture of fibroblastoid and hematopoietic cell types. Here we report a reliable method based on immunodepletion to fractionate fibroblastoid cells from hematopoietic cells within plastic adherent murine marrow cultures. The immunodepleted cells expressed the antigens Sca-1, CD29, CD44, CD81, CD106, and the stem cell marker nucleostemin (NST) but not CD11b, CD31, CD34, CD45, CD48, CD90, CD117, CD135, or the transcription factor Oct-4. They were also capable of differentiating into adipocytes, chondrocytes, and osteoblasts in vitro as well as osteoblasts/osteocytes in vivo. Therefore, immunodepletion yields a cell population devoid of hematopoietic and endothelial cells that is phenotypically and functionally equivalent to MSCs. The immunodepleted cells exhibited a population doubling time of approximately 5-7 days in culture. Poor growth was due to the dramatic down regulation of many genes involved in cell proliferation and cell cycle progression as a result of immunodepletion. Exposure of immunodepleted cells to fibroblast growth factor 2 (FGF2) but not insulin-like growth factor (IGF), murine stem cell factor, or leukemia inhibitory factor (LIF) significantly increased their growth rate. Moreover, 82% of the transcripts down regulated by immunodepletion remain unaltered in the presence of FGF2. Exposure to the later also reversibly inhibited the ability of the immunodepleted cells to differentiate into adipocytes, chondrocytes, and osteoblasts in vitro. Therefore, FGF2 appears to function as a mitogen and self-maintenance factor for murine MSCs enriched from bone marrow by negative selection. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898521     DOI: 10.1002/jcb.10594

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  178 in total

1.  Effects of serum and serum heat-inactivation on human bone derived osteoblast progenitor cells.

Authors:  A Bruinink; U Tobler; M Hälg; J Grünert
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

Review 2.  Molecular mediators of mesenchymal stem cell biology.

Authors:  Maria P Alfaro; Sarika Saraswati; Pampee P Young
Journal:  Vitam Horm       Date:  2011       Impact factor: 3.421

3.  Isolation of the stromal-vascular fraction of mouse bone marrow markedly enhances the yield of clonogenic stromal progenitors.

Authors:  Colby Suire; Nathalie Brouard; Karen Hirschi; Paul J Simmons
Journal:  Blood       Date:  2012-01-18       Impact factor: 22.113

4.  The isolation and characterization of putative mesenchymal stem cells from the spiny mouse.

Authors:  Hayley Dickinson; Phillipa Milton; Graham Jenkin
Journal:  Cytotechnology       Date:  2012-02-26       Impact factor: 2.058

5.  Molecular analysis of the differentiation potential of murine mesenchymal stem cells from tissues of endodermal or mesodermal origin.

Authors:  Claudia Concer Viero Nora; Melissa Camassola; Bruno Bellagamba; Nilo Ikuta; Ana Paula Christoff; Lindolfo da Silva Meirelles; Raquel Ayres; Rogério Margis; Nance Beyer Nardi
Journal:  Stem Cells Dev       Date:  2011-11-22       Impact factor: 3.272

6.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Authors:  Ulrich Lindner; Jan Kramer; Jürgen Rohwedel; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

Review 7.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

8.  Differentiation character of adult mesenchymal stem cells and transfection of MSCs with lentiviral vectors.

Authors:  Xiayi Zhang; Jinsong Li; Jun Nie; Ke Jiang; Zhikun Zhen; Jianjun Wang; Lin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

9.  Aire controls mesenchymal stem cell-mediated suppression in chronic colitis.

Authors:  Biju Parekkadan; Anne L Fletcher; Matthew Li; Melissa Y Tjota; Angelique Bellemare-Pelletier; Jack M Milwid; Je-Wook Lee; Martin L Yarmush; Shannon J Turley
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

10.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.